Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Frontiers in Oncology|June 1, 2022
Beyond Clinical Trials in Patients With Multiple Myeloma: A Critical Review of Real-World ResultsLuca Bertamini, Giuseppe Bertuglia, Stefania OlivaJournal of Clinical Medicine|July 11, 2020
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future PerspectivesRoberto Mina, Stefania Oliva, Mario BoccadoroCancer Journal (Sudbury, Mass.)|September 22, 2021
Minimal Residual Disease in Multiple Myeloma: Ready for Prime Time?Roberto Mina, Francesca Bonello, Stefania OlivaExpert Review of Anticancer Therapy|May 17, 2018
A look at treatment strategies for relapsed multiple myelomaGiusy Cetani, Mario Boccadoro, Stefania OlivaJournal of Clinical Medicine|August 23, 2020
Erratum: Mina, R.; et al. Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives. J. Clin. Med. 2020, 9, 2142Roberto Mina, Stefania Oliva, Mario BoccadoroFrontiers in Oncology|February 21, 2020
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple MyelomaStefania Oliva, Mattia D'Agostino, Mario Boccadoro, et al.Expert Opinion on Biological Therapy|August 11, 2017
Systemic virotherapy for multiple myelomaStefania Oliva, Manuela Gambella, Mario Boccadoro, et al.Frontiers in Immunology|December 13, 2018
Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple MyelomaStefania Oliva, Rossella Troia, Mattia D'Agostino, et al.Cancers|December 19, 2019
Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic StrategiesMattia D'Agostino, Luca Bertamini, Stefania Oliva, et al.International Journal of Hematology-Oncology and Stem Cell Research|August 28, 2023
Atypical Course of SarsCov-2 Infection in a Patient with Multiple Myeloma Treated with Autologous Stem Cell TransplantationGianluca Isaia, Silvia Valerio, Stefania Oliva, et al.Pageof 6